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Aortic dissection is a complex manifestation of disease of the arterial wall. The severity and consequences of a dissection are
related to the physical characteristics and anatomic location of the tear as well as the underlying patient physiology. Despite
in vitro and in vivo modeling advances, our understanding of the pathophysiology has been limited to evaluations of the
success and failure of various treatment modalities. The indications for intervention have historically included rupture,
intractable pain or hypertension, distal ischemia and degeneration of the aortic wall causing aneurysm formation.
The management decisions for patients with dissections are dependent upon the abnormal anatomy, the acuity of the patient
presentation, and physiology. Despite the availability of open surgery as a therapeutic option, acute dissections with evidence
of ischemia are now handled using an endovascular approach that is specifically directed at the cause of the ischemia.
Endovascular treatments include the placement of a stentgraft into the proximal aorta, branch vessel stenting, uncovered
stent placement in the abdominal aorta, and aortic fenestrations. Chronic dissections, in contrast, are still most frequently
managed with open surgical techniques. However, a subset of patients that are not candidates for traditional surgical repair
of the thoracoabdominal aorta may be managed with a combined open mesenteric revascularization with subsequent
endovascular grafting of the thoracoabdominal aorta.
Key Words: Aortic dissections; Thoracic aneurysm; Thoracic dissection; Endograft; Endovascular fenestration; Thoracic
endovascular repair.
Introduction
Stanford type B aortic dissections result in an annual
mortality rate in excess of that reported for ruptured
aneurysms. Despite the plethora of treatments that
have been advocated over the past 80 years, the
consequences of this disease remain devastating.
Deaths occur as a result of end organ ischemia or
aortic rupture. Acute mortality has been most closely
associated with ischemic complications, while long-
term mortality is traditionally linked to aortic degener-
ation and late rupture. Ischemic complications have
been reported to occur in up to 30% of all cases of type
B dissections.1 – 5 Rupture, on the other hand is less
common in the acute setting but still occurs in up to
20% of patients over their life-span. Although a great
deal of progress has been made since the inception of
the management of aortic dissection clinical sequelae
in 1935,6 contemporary reports still harbor exception-
ally high mortality rates in the subset of patients that
suffer ischemic complications (16–25%).3 – 5,7
Open surgical techniques include central or focal
descending thoracic aortic replacement, diffuse aortic
replacement (thoracoabdominal repair), and open
fenestration techniques. Interventional techniques
include visceral vessel stenting, aortic fenestration,
and the use of covered or uncovered stents in the aorta.
Although many therapies have attempted to address
the acute circumstances the disease creates, the
underlying pathophysiology of the disease remains
confusing and complicates outcome analysis. Most
treatments are viewed as partially effective, and leave
clinicians with several questions regarding the appro-
priate management in the acute and chronic settings.
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Materials and Methods
Papers and studies for this review were identified by
Medline and Pubmed literature searches using key-
words aortic dissection, type B dissection, visceral
ischemia, thoracic endograft, and aortic fenestration.
Articles were obtained and evaluated by the authors of
this manuscript. Inclusion in this review was depen-
dent on the relevance to the subject, and the ability to
discern the acuity of patient presentation, symptoms,
and the presence of dissection as opposed to aneur-
ismal disease. In an effort to provide a comprehensive
treatment paradigm for this complex patient popu-
lation, we have included data from our institution as
well in this review.
Pathophysiology
An understanding of the pathophysiologic mechan-
isms of an aortic dissection has the potential to help
direct therapeutic options. Unfortunately, despite
several studies assessing anatomic and physiologic
variants pertaining to dissected aortas including tear
depth,8 local wall stress,9 the status of the vaso
vasorum,10 and the angulation of the initial entry
tear.11 We have been largely unsuccessful in defining
specific anatomic parameters predictive of acute or
long-term complications from aortic dissections,8,9,
12 – 14 Attention to physiologic details, pulse examin-
ations, subtle symptoms, and serum markers indica-
tive of low grade ischemia will allow physicians an
opportunity to intervene prior to hemodynamic
decompensation and the potential for end organ tissue
loss. However, certain generalizations can be made
about dissections. Anatomic categorization coupled
with physiologic information is most helpful in
determining treatment options and predicting out-
comes. Patients with acute dissection presenting with
ischemic complications have fared worse than those
with relatively minimal symptoms such as back pain
or hypertension. Chronic dissections typically have
complex true and false lumen relationships; most
frequently include extensive distal aortic or iliac
involvement. Untreated type A dissections have been
universally associated with dismal outcomes, while
only a subset of type B dissections result in compli-
cations that mandate acute treatments. Contemporary
reports must be viewed in the context of the indication
for treatment, the pathophysiology of the involved
patients, the type of treatment performed and the
endpoints assessed. For example, a patient in extreme
duress with mesenteric ischemia may be considered
successfully managed if they survive to hospital
discharge, while a patient treated for a chronic
dissection in the setting of an enlarging aorta would
be deemed successful if growth was arrested or the
aneurysm excluded with false lumen thrombosis.
Acute dissections
Acute dissections originating distal to the left sub-
clavian artery without arch involvement have been
historically treated medically unless specific symp-
toms, such as ischemia, rupture or rapid growth are
detected. In the absence of such, antihypertensive
therapy with beta blockade or combination alpha and
beta blockade has been the primary method of
minimizing the long-term complications. The devel-
opment of an ischemic syndrome is the most fre-
quently encountered morbidity and requires rapid
treatment to prevent mortality. Unfortunately, conven-
tional treatments in these circumstances have been
associated with mortality rates up to 80%. Newer
endovascular methods have been noted to markedly
diminish the mortality rates for this condition, but lack
long-term results and have been reported in series
with small numbers of patients.
Mechanisms of ischemia
The lack of an early marker or indicator of which
patients with aortic dissections will suffer a cata-
strophic complication such as visceral ischemia has
thwarted our ability to treat patients prior to the
development of extreme physiologic duress. Two
pathophysiologic mechanisms of ischemia have been
proposed.12,13,15,16 The first involves compression of
the true lumen within the descending thoracic aorta.
This process occurs, most commonly, in the setting of a
deep proximal tear with an absence of a large distal
fenestration. The mean false lumen pressure increases
rapidly, as a result of poor outflow, which in turn
results in true lumen compression that ultimately
inhibits flow to the viscera and lower extremities. If a
large distal fenestration is present, the false lumen acts
in a manner similar to that of a shunt, thus distal
ischemia is rarely noted because flow is not compro-
mised. If the dissection plane propagates into a
visceral or lower extremity branch, individual branch
ischemia may be noted. Although many branch vessel
dissections are without sequellae, two types of
symptomatic branch vessel obstructions can develop.
The obstruction can result from a false lumen that has
occluded where thrombus resides at the ostium of the
branch vessel, or the flow impingement can occur if
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the dissection flap functions similar to a mechanical
valve oscillating with the pulsatile aortic flow, occlud-
ing the visceral vessel ostium during systole, and
allowing flow during diastole.15
Interventional strategies
The hemodynamics of aortic dissections must be
viewed in the context of cardiovascular physiology
and the material properties of the aorta. The inability
of an uncovered stent to direct flow away from the
false lumen relegates any benefit of such a stent to
presence of radial force. The amount of radial force
required to collapse the false lumen, that typically has
a mean arterial pressure in excess of the true lumen,
may be greater than the aortic wall strength. It is
furthermore difficult to distribute the force equally
along the aortic adventitia in the setting of a dissection
with irregular flap morphology or tortuosity that
compounds the problem. Animal studies,17 – 19 as
well as early clinical experiences have reinforced this
concept. Aortic fenestration techniques have a role in
select cases. This method of therapy functions by
equalizing blood pressure differentials between the
true and false lumen, allowing passive equalization of
flow channels. Short-term success with observed
resolution of ischemia of the mesentery or lower
extremities has been reported.3,20 However, it is
unlikely that this technique will aid in the prevention
of long-term aortic degeneration, given the persistence
of flow within both lumens and the obligatory
diminished wall thickness of each portion of the
aorta. It appears that the best management strategy
would be to minimize flow and pressurization of the
false lumen to treat proximal obstruction and also to
prevent aortic enlargement over time.
Management of acute dissections with ischemic
complications
The assessment of the patient suffering complications
from an acute aortic dissection must entail a careful
evaluation of both the true and false lumens. Treat-
ment must be directed in a manner that accommodates
the complex hemodynamics, luminal relationships,
and anatomic points of luminal communication as
well as branch vessel flow. The choice of therapy must
center on the degree of true lumen compression and
the patency of the false lumen (Fig. 1). In the setting of
true lumen compression with dissection into branch
vessels, critical branches may be protected, if time
permits, by the placement of self-expanding stents
within them to ensure true lumen supply of blood to
the end organ. This would be followed by the
placement of an endovascular stent graft proximally
over the major fenestration in an effort to block false
lumen inflow, allowing for passive contraction of the
false lumen, resulting in true lumen expansion. In
the absence of branch vessel dissection, placement of
the aortic prosthesis usually suffices. These techniques
carry the potential to provide the majority of end
organs with flow derived from the true lumen.
Endovascular fenestration of the aorta is performed
only when definitive access to the true lumen cannot
be achieved or one is unable to ensure adequate flow
to branch vessels following placement of an endovas-
cular prosthesis. However, passive expansion of the
true lumen and contraction of the false lumen will
occur only in the setting of a patent false lumen. When
false lumen occlusion is observed and confirmed, true
lumen expansion can be accomplished with the use of
flexible uncovered stents, allowing stent placement
across visceral ostia. This can be accomplished with
the use of a relatively small amount of radial force, as
compression of the thrombosed false lumen is quite
simple in the absence of the relatively high mean
arterial pressure typically found in a patent false
lumen. This must be carefully assessed because if there
is false lumen perfusion, the pulsatile forces induced
by the false lumen transmitted to any stent through the
dissection membrane are likely to overcome any
amount of opposing radial force, and severely chal-
lenge the devices from the standpoint of material
fatigue.
Chronic dissections
Unlike the emergent situation encountered when
intervening on acute dissections, the indication for
intervention in chronic dissection generally allows for
a well-planned, elective approach. Given the invasive-
ness of traditional thoracoabdominal repair resulting
from chronic dissections, there is a strong desire to
develop other treatment methods. However, it is rare
that the dissected aorta has anatomy allowing for a
proximal and distal seal with an endovascular
prosthesis. More typically, the dissection extends into
the visceral aortic segment where multiple fenestra-
tions between the two lumens exist. These preclude
complete exclusion of the false lumen with an
endovascular approach and it remains unclear
whether partial exclusion of the false lumen will affect
aortic growth or rupture in a beneficial fashion. In this
light, we treat patients with an open surgical approach
if they are acceptable candidates. However, in some
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circumstances, such as patients with severe pulmon-
ary disease, cannot tolerate the thoracic portion of the
procedure. In these cases a four vessel mesenteric
bypass deriving inflow from the left common iliac
artery can be performed through a retroperitoneal
incision extending to the 12th rib. This avoids a
thoracotomy, theoretically diminishing the pulmonary
risks and precedes stentgrafting of the entire thoracic
and abdominal aorta (Figs. 2 and 3). Obviously, the
development of a branch vessel endovascular device
would supplant this fairly cumbersome and relatively
invasive combined approach. However, the use of a
branch vessel device in a dissected aorta may prove to
be significantly more challenging than its use within a
non-specific thoracoabdominal aneurysm.
Discussion
Aortic dissection treatment paradigms have evolved
with the development of new endovascular tools and
the better understanding of the pathophysiology of
this disease. These new paradigms have been reported
by experienced centers involved in the treatment of
aortic dissections, where surgeons, radiologists, and
cardiologists are incorporated in a team approach
optimizing the management of these patients. Prior to
embarking on interventional treatments for aortic
dissections, extensive experience with endovascular
techniques, especially aortic endografting, is viewed
as mandatory owing to the complex nature of the
required interventions and unforgiving aspects of the
disease state.
No definitive evidence is available demonstrating
the superiority of endovascular treatment in contrast
to open surgical techniques for acute dissections
presenting with life-threatening complications (ische-
mia, aortic rupture). However, in this subset of
patients, endovascular treatments performed by
experienced teams have shown more favorable out-
comes7 than open surgical series that report mortality
rates between 50 and 85%.3,4,21,22 Much of the
endovascular success can be attributed to the mini-
mally invasive aspect of the treatments in conjunction
with the rapidity by which distal aortic perfusion is
restored.
Fig. 1. The development of ischemia (visceral vessel or lower extremity) following an aortic dissection has traditionally been
managed with open surgery or endovascular fenestration techniques. The current treatment paradigm utilized at our
institution is depicted here. Note the importance of an early imaging study allowing the differentiation between patients with
true lumen compromise and those with branch vessel obstruction due to the distal extent of the dissection. Additionally, the
absence of endovascular fenestration techniques in this treatment paradigm represents our reluctance to use this therapeutic
modality in preference of endovascular grafting technology. The exception to this occurs when true lumen compression is
limited to the visceral aortic segment where endovascular graft deployment would prevent flow to visceral branches.
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Dake et al.7 reported a series of 19 acute dissections
treated with thoracic stent-grafts (4 type A and 15 type
B), 11 with symptomatic branch-vessel obstruction,
and three with aortic rupture. There were three early
mortalities (16%), and three patients with serious early
complications. After stent-graft placement, all branch-
vessel obstruction resulting from true lumen com-
pression, and 40% of those obstructions attributed to a
combination of true lumen compression and branch
involvement were reperfused. Additional uncovered
stents were required in the true lumen of the branch
vessels with residual obstruction to restore luminal
patency. Kato and Shimono23,24 published results on a
series of patients with thoracic endografts placed for
acute dissection (16 with complications, 8 without),
and chronic dissections ðn ¼ 13Þ. Acute dissection
treatments were limited to hemodynamically stable
patients with only one early mortality in this group.
Palma et al.25 published a series of 35 acute (without
branch vessel ischemia) and 23 chronic type B
dissections out of a series of 65 patients treated with
thoracic endografts. They reported an early mortality
rate of 6%.
Disparate mortality rates likely pertain to
patient selection bias and the acuity or pretreatment
physiologic status of the patients in the respective
series. Acute reperfusion injuries and multisystem
organ failure following multiple laparotomies with
bowel resections have been responsible for the
majority of deaths. The reperfusion injuries we have
witnessed have been dramatic and isolated to patients
with severely compressed true lumens. Severe pro-
blems have arisen from hyperkalemia, and subsequent
patients have been treated by maximizing medical
prophylaxis in such cases, and in one case, utilized
intraoperative hemodialysis prior to endograft
deployment.
The need for visceral vessel stenting in conjunction
with endovascular grafting has also become somewhat
controversial. Some authors have felt that adjunctive
stents within dissected branch vessels are unnecess-
ary.7,26 However, following three cases where we were
unable to regain access to vessels supplied by a false
lumen that was collapsed by a proximal endovascular
graft, have become more aggressive in the establish-
ment of true lumen inflow to branch vessels supplied
by the false lumen. Ultimately, the decision as to
whether a branch vessel is stented prior to the
placement of an endovascular prosthesis is dependent
on the time required to perform such a procedure, the
effect of delayed true lumen expansion, and the risk of
branch vessel closure. Fig. 1 depicts the treatment
paradigm utilized at our institution in the setting of a
patient suffering acute dissection with ischemia
complications.
Traditionally, asymptomatic dissections are mana-
ged with aggressive antihypertensive regimens and
careful follow-up. However, long-term data suggest
that up to 30–40%27 of these patients will ultimately
succumb to an aortic-related death or require a direct
aortic intervention over a 7-year period. Consequently,
we must carefully evaluate any mechanism that may
diminish the rate of aortic growth. Treatment at the
time of acute presentation appears to be most
promising. Initially, the dissection flap is free of
hypertrophy and extremely mobile. Success in achiev-
ing complete false lumen thrombosis may be most
probably at this time point. Were this to occur, the
acute dissections would be converted into an intra-
mural hematoma, which has the potential to heal and
decrease the incidence of long-term aortic degener-
ation. Proof of this concept would require a prospec-
tive randomized trial involving asymptomatic
dissections where endovascular grafting of the prox-
imal fenestration would be contrasted with a medi-
cally managed arm.
In the setting of a chronic dissection, complete and
durable exclusion of the aneurysmal false lumen, and
restoration of the blood flow into the true lumen,
Fig. 2. This demonstrates the completed 4 vessel visceral
bypass procedures (label 1 denotes the celiac bypass, 2 the
superior mesenteric bypass, 3 the right renal bypass, and 4
the native left renal anastomosed to the celiac limb). The
visceral bypass portion of this procedure was performed in
conjunction with replacement of the infra-renal aorta. A
bifurcated graft was sewn onto the aortic graft in a
retrograde manner to provide inflow for the visceral
segment. The proximal anastomosis, in this setting, is sewn
to short segment of normal caliber aorta with the intent of
providing a better landing zone for the endoprosthesis,
above the retrograde bypass grafts for all of the mesenteric
vessels.
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should be achieved to consider treatment success.
Because of the thickness of the intimal flap, the
presence of multiple re-entry tears, and flow to aortic
branches provided by the false lumen, endografting in
our experience has limited indications. However, good
results of endovascular exclusion have been reported
in selected patients. Nienaber et al.26 reported a series
of 12 cases of aortic sub-acute or chronic dissection
treated with endografts. The indications for treatment
were a maximal aortic diameter of 5.5 cm or more,
luminal expansion, and recurrent pain. No patients
with visceral branch-vessel obstruction were included
in this study. At 3 months, complete thrombosis of the
false lumen was documented in all patients, with clear
evidence of expansion of the true lumen and shrinkage
of the false lumen. In Kato and Shimono’s series,23,24
13 chronic dissections with major branch vessels
supplied by the true lumen were treated with
endografts. During follow-up (27 months), complete
obliteration of the false lumen was noted in 38.5% of
patients with chronic dissection, compared to 70% of
patients with acute dissections. This last series
confirms the difficulties to definitively exclude the
false lumen in patients with chronic dissection treated
with endografts. We therefore utilise a conventional
open surgical approach if the patient has acceptable
risk factors. In patients perceived to be incapable of
tolerating a traditional repair, a combined endovas-
cular and open procedure involving visceral and renal
bypass grafting with thoracoabdominal stentgrafting
has been performed (Fig. 4).
The treatment paradigms sited in this manuscript
incorporate the majority of the recently published
series combined with our own experience. The use of
endovascular techniques in the setting of acute aortic
dissections associated with peripheral ischemia or
Fig. 3. Images A, B, C, and D depict the completion angiogram following the placement of an endovascular prosthesis
implanted into an elephant trunk (A), with the remainder of the thoracic and abdominal aorta (B and C), all the way down to
the aortic bifurcation. A mesenteric bypass operation (including the celiac, SMA, and both renal arteries) preceded the
endograft placement. Alternative inflow options for the visceral branches include either common iliac artery as depicted in
images C and D.
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aortic rupture, has the potential to dramatically
improve early survival but requires skills inclusive of
open surgery, aortic endografting, and branch vessel
stenting. Acute dissections without life-threatening
complications may be candidates for studies evaluat-
ing aortic endografts with the intent of preventing
long-term complications. Chronic aortic dissection
repair, in the setting of thoracoabdominal aneurysms
is best handled surgically, unless the patient is
incapable of tolerating this approach. Endovascular
treatments combined with open surgery techniques
have been successful yet remain investigative.
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